Heather Hamel - 07 Jul 2022 Form 3 Insider Report for INVIVO THERAPEUTICS HOLDINGS CORP.

Role
Chief Legal Officer and GC
Signature
Heather Hamel
Issuer symbol
N/A
Transactions as of
07 Jul 2022
Net transactions value
$0
Form type
3
Filing time
18 Jul 2022, 21:31:10 UTC
Next filing
21 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NVIV COMMON STOCK 750 07 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NVIV Stock Option 07 Jul 2022 Common Stock 1 $49500.00 Direct F1
holding NVIV Stock Option 07 Jul 2022 Common Stock 1 $78750.00 Direct F1
holding NVIV Stock Option 07 Jul 2022 Common Stock 1 $138187.50 Direct F1
holding NVIV Stock Option 07 Jul 2022 Common Stock 1 $81562.50 Direct F1
holding NVIV Stock Option 07 Jul 2022 Common Stock 960 $27.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All the shares underlying this option have vested and are exercisable.
F2 Half of the shares underlying this option vested on 3/18/22 and the other half shall vest on 3/18/23.

Remarks:

Exhibit Index: 24.1 Power of Attorney